PS Ratio: 38.13

Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/S ratio high or low?

The P/S ratio of 38.13 is 80% below its estimated 5-year average of 193.73, near the low end of its estimated 5-year range (12.16–14937.40).

As of 2026-10-06T19:36:59.368Z. 19.79% below its estimated 12-month average of 47.54.

HUMA PS Ratio Metrics

P/S vs. estimated history

At 38.13, P/S is at an extreme level, where the multiple carries little signal — higher than 19% of readings in its estimated 6-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

Sales Valuation

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PS Ratio FAQ

What is the P/S ratio for Humacyte, Inc. (HUMA)?

The P/S ratio for HUMA stock is 38.13.

Is Humacyte, Inc.'s P/S ratio high or low?

The P/S ratio of 38.13 is 80% below its estimated 5-year average of 193.73, near the low end of its estimated 5-year range (12.16–14937.40).

What is the estimated TTM average P/S ratio for Humacyte, Inc. (HUMA)?

The estimated TTM average P/S ratio for HUMA stock is 47.54.

What is the estimated 3Y average P/S ratio for Humacyte, Inc. (HUMA)?

The estimated 3Y average P/S ratio for HUMA stock is 42.12.

What is the estimated 5Y average P/S ratio for Humacyte, Inc. (HUMA)?

The estimated 5Y average P/S ratio for HUMA stock is 193.73.

Showing the most recent 260 of 1,069 data points. The chart above shows the full history.

Related Metrics